Assignee
IMPAX LABORATORIES INC
US12 patents
Top patents by PatentIndex Score
US8377474B2Feb 19, 2013
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC48 citations97
US10292935B2May 21, 2019
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES INC30 citations94
US10098845B2Oct 16, 2018
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
IMPAX LABORATORIES INC28 citations94
US6333332B1Dec 25, 2001
Stabilized pharmaceutical compositions containing bupropion hydrochloride
IMPAX LABORATORIES INC170 citations93
US7094427B2Aug 22, 2006
Combination immediate release controlled release levodopa/carbidopa dosage forms
IMPAX LABORATORIES INC60 citations91
US6531158B1Mar 11, 2003
Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
IMPAX LABORATORIES INC21 citations84
US9463246B2Oct 11, 2016
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC3 citations82
US9089608B2Jul 28, 2015
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC6 citations82
US9089607B2Jul 28, 2015
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC5 citations82
US8007827B2Aug 30, 2011
Pharmaceutical dosage forms having immediate release and/or controlled release properties
IMPAX LABORATORIES INC17 citations79
US9901640B2Feb 27, 2018
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC0 citations47
US9533046B2Jan 3, 2017
Controlled release formulations of levodopa and uses thereof
IMPAX LABORATORIES INC0 citations47